ATNM
Actinium Pharmaceuticals Inc. (ATNM)
NYSE · Healthcare
Actinium Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Actinium Pharmaceuticals Inc. revenue for the quarter ending September 30, 2025 was 90000, a 100.00% increase year-over-year.
- Actinium Pharmaceuticals Inc. revenue for the twelve months ending September 30, 2025 was 1.1 M, a 0.09% decrease year-over-year.
- Actinium Pharmaceuticals Inc. annual revenue for 2025 was 90000, a 11.11% increase from 2023.
- Actinium Pharmaceuticals Inc. annual revenue for 2023 was 81000, a 92.14% decrease from 2022.
- Actinium Pharmaceuticals Inc. annual revenue for 2022 was 1.0 M, a 9.97% decrease from 2021.
- Actinium Pharmaceuticals Inc. annual revenue for 2021 was 1.1 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Actinium Pharmaceuticals Inc. Earnings — FAQ
Actinium Pharmaceuticals Inc. (ATNM) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATNM's earnings history?
The chart and table above show Actinium Pharmaceuticals Inc.'s earnings by year and by quarter, including the growth rate.